Bell Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-53,202
| Closed | -$3.86M | – | 65 |
|
|
2025
Q1 | $3.86M | Sell |
53,202
-930
| -2% | -$67.4K | 0.71% | 63 |
|
|
2024
Q4 | $4.01M | Sell |
54,132
-43,195
| -44% | -$3.2M | 0.73% | 60 |
|
|
2024
Q3 | $6.42M | Sell |
97,327
-5,555
| -5% | -$367K | 1.18% | 36 |
|
|
2024
Q2 | $9.5M | Sell |
102,882
-24,458
| -19% | -$2.26M | 1.33% | 25 |
|
|
2024
Q1 | $12.2M | Sell |
127,340
-49,017
| -28% | -$4.68M | 1.78% | 14 |
|
|
2023
Q4 | $13.4M | Buy |
176,357
+49,314
| +39% | +$3.76M | 2.05% | 6 |
|
|
2023
Q3 | $8.8M | Buy |
127,043
+40,578
| +47% | +$2.81M | 1.45% | 30 |
|
|
2023
Q2 | $8.16M | Sell |
86,465
-14,196
| -14% | -$1.34M | 1.4% | 39 |
|
|
2023
Q1 | $8.33M | Buy |
100,661
+10,688
| +12% | +$884K | 1.52% | 28 |
|
|
2022
Q4 | $6.71M | Buy |
89,973
+24,741
| +38% | +$1.85M | 1.26% | 43 |
|
|
2022
Q3 | $5.39M | Sell |
65,232
-783
| -1% | -$64.7K | 1.09% | 50 |
|
|
2022
Q2 | $6.28M | Buy |
66,015
+2,788
| +4% | +$265K | 1.24% | 47 |
|
|
2022
Q1 | $7.44M | Buy |
63,227
+8,343
| +15% | +$982K | 1.28% | 41 |
|
|
2021
Q4 | $7.11M | Buy |
54,884
+262
| +0.5% | +$33.9K | 1.15% | 48 |
|
|
2021
Q3 | $6.18M | Buy |
54,622
+2,049
| +4% | +$232K | 1.05% | 52 |
|
|
2021
Q2 | $5.45M | Sell |
52,573
-229
| -0.4% | -$23.7K | 1.07% | 51 |
|
|
2021
Q1 | $4.42M | Buy |
+52,802
| New | +$4.42M | 0.95% | 55 |
|